Literature DB >> 16788010

Charcot-Marie-Tooth disease type 1A duplication with severe paresis of the proximal lower limb muscles: a long-term follow-up study.

J Berciano1, E Gallardo, A García, J Infante, I Mateo, O Combarros.   

Abstract

OBJECTIVE: To describe a large pedigree with Charcot-Marie-Tooth disease type 1A (CMT1A) duplication in which severe pelvic and thigh musculature weakness occurred in two patients, detected by analysing the leg muscle atrophy pattern on magnetic resonance imaging (MRI).
METHODS: The pedigree comprised 18 patients, aged between 15 and 85 (median 46) years, who were serially evaluated for up to three decades. All 18 patients and 13 non-affected at-risk people underwent electrophysiological examination. An MRI study of lower limb musculature was carried out in four patients. Three patients underwent sural-nerve biopsy. Genetic testing was carried out in 17 patients and in all 13 at-risk normal people.
RESULTS: Fourteen patients were asymptomatic or slightly disabled. The two oldest patients, aged 84 and 80, showed a moderate phenotype. Two other patients, aged 70 and 53, showed late-onset and gradually progressive peroneal paresis extending up to the thigh and pelvic musculature, resulting in waddling gait. MRI scans of all three patients with a mild phenotype showed subtle and subclinical fatty infiltration of calf anterolateral muscle compartments, with thigh muscle involvement in one patient, and extensive atrophy of intrinsic foot muscles. In the youngest patient with proximal leg weakness, the MRI scan showed massive fatty atrophy of all the calf muscles, posteromedial thigh muscle compartments, and internal and external hip rotator muscles. Sural-nerve biopsy specimens showed hypertrophic neuropathy with no superimposed inflammation. Good correlation was seen between electrophysiological and genetic testing.
CONCLUSIONS: Late in the clinical course, a small proportion of patients with CMT1A develop severe proximal leg weakness, and long-term follow-up is essential for its detection. MRI scans may show subclinical involvement of the thigh musculature.

Entities:  

Mesh:

Year:  2006        PMID: 16788010      PMCID: PMC2077541          DOI: 10.1136/jnnp.2006.093443

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  37 in total

Review 1.  MR imaging in nonneoplastic muscle disorders of the lower extremity.

Authors:  Joshua M Farber; Kenneth A Buckwalter
Journal:  Radiol Clin North Am       Date:  2002-09       Impact factor: 2.303

2.  Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies.

Authors:  P J Dyck; E H Lambert
Journal:  Arch Neurol       Date:  1968-06

3.  Absence of linkage of hereditary motor and sensory neuropathy type I to chromosome 1 markers.

Authors:  H R Middleton-Price; A E Harding; J Berciano; J M Pastor; S M Huson; S Malcolm
Journal:  Genomics       Date:  1989-02       Impact factor: 5.736

4.  The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies.

Authors:  R A Lewis; A J Sumner
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

5.  Coexistent hereditary and inflammatory neuropathy.

Authors:  Lionel Ginsberg; Omar Malik; Anthony R Kenton; David Sharp; John R Muddle; Mary B Davis; John B Winer; Richard W Orrell; Rosalind H M King
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

6.  The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I.

Authors:  J Berciano; O Combarros; J Calleja; J M Polo; C Leno
Journal:  Muscle Nerve       Date:  1989-04       Impact factor: 3.217

7.  Dominantly inherited motor and sensory neuropathy type I. Genetic, clinical, electrophysiological and pathological features in four families.

Authors:  O Combarros; J Calleja; J Figols; A Cabello; J Berciano
Journal:  J Neurol Sci       Date:  1983-10       Impact factor: 3.181

8.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

9.  Initial semeiology in children with Charcot-Marie-Tooth disease 1A duplication.

Authors:  José Berciano; Antonio García; Onofre Combarros
Journal:  Muscle Nerve       Date:  2003-01       Impact factor: 3.217

10.  Longitudinal study of neuropathic deficits and nerve conduction abnormalities in hereditary motor and sensory neuropathy type 1.

Authors:  P J Dyck; J L Karnes; E H Lambert
Journal:  Neurology       Date:  1989-10       Impact factor: 9.910

View more
  16 in total

1.  NEFL E396K mutation is associated with a novel dominant intermediate Charcot-Marie-Tooth disease phenotype.

Authors:  José Berciano; Antonio García; Kristien Peeters; Elena Gallardo; Els De Vriendt; Ana L Pelayo-Negro; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

2.  Clinical progression in Charcot-Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family.

Authors:  José Berciano; Elena Gallardo; Antonio García; César Ramón; Jon Infante; Onofre Combarros
Journal:  J Neurol       Date:  2010-05-05       Impact factor: 4.849

3.  MRI findings, patterns of disease distribution, and muscle fat fraction calculation in five patients with Charcot-Marie-Tooth type 2 F disease.

Authors:  Michele Gaeta; Achille Mileto; Anna Mazzeo; Fabio Minutoli; Rita Di Leo; Nicola Settineri; Rocco Donato; Giorgio Ascenti; Alfredo Blandino
Journal:  Skeletal Radiol       Date:  2011-05-25       Impact factor: 2.199

4.  Evolution of Charcot-Marie-Tooth disease type 1A duplication: a 2-year clinico-electrophysiological and lower-limb muscle MRI longitudinal study.

Authors:  Ana L Pelayo-Negro; Elena Gallardo; Antonio García; Pascual Sánchez-Juan; Jon Infante; José Berciano
Journal:  J Neurol       Date:  2014-01-22       Impact factor: 4.849

5.  Texture analysis using T1-weighted images for muscles in Charcot-Marie-Tooth disease patients and volunteers.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Hyun Su Kim; Jae-Hun Kim; Byung-Ok Choi
Journal:  Eur Radiol       Date:  2020-10-30       Impact factor: 5.315

6.  Magnetic resonance imaging findings of leg musculature in Charcot-Marie-Tooth disease type 2 due to dynamin 2 mutation.

Authors:  Elena Gallardo; Kristl G Claeys; Eva Nelis; Antonio García; Ana Canga; Onofre Combarros; Vincent Timmerman; Peter De Jonghe; José Berciano
Journal:  J Neurol       Date:  2008-06-17       Impact factor: 4.849

7.  Charcot–Marie–Tooth disease type 2J with MPZ Thr124Met mutation: clinico-electrophysiological and MRI study of a family.

Authors:  Elena Gallardo; Antonio García; César Ramón; Elías Maraví; Jon Infante; Itziar Gastón; Ángel Alonso; Onofre Combarros; Peter De Jonghe; José Berciano
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

8.  Distal hereditary motor neuropathy in Korean patients with a small heat shock protein 27 mutation.

Authors:  Ki Wha Chung; Sang-Beom Kim; Sun Young Cho; Su Jin Hwang; Sun Wha Park; Sung Hee Kang; Joonki Kim; Jeong Hyun Yoo; Byung-Ok Choi
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

9.  Relationship between clinical examination, quality of life, disability and depression in CMT patients: Italian multicenter study.

Authors:  L Padua; I Aprile; T Cavallaro; I Commodari; D Pareyson; A Quattrone; N Rizzuto; G Vita; P Tonali; A Schenone
Journal:  Neurol Sci       Date:  2008-07-09       Impact factor: 3.307

10.  NEFL N98S mutation: another cause of dominant intermediate Charcot-Marie-Tooth disease with heterogeneous early-onset phenotype.

Authors:  José Berciano; Kristien Peeters; Antonio García; Tomás López-Alburquerque; Elena Gallardo; Arantxa Hernández-Fabián; Ana L Pelayo-Negro; Els De Vriendt; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2015-12-08       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.